SPONSOR
Shanghai Chest Hospital
Total Trials
8
Recruiting
8
Phases
Phase 2, Phase 3
Conditions studied: Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)Stage II-III Non-small Cell Lung CancerEsophageal Squamous Cell CarcinomaEsophageal CancerMetastatic Esophageal Squamous Cell CarcinomaSmall-cell Lung CancerSmall Cell Lung Cancer, Combined TypeSmall Cell Lung CarcinomaSmall Cell Lung Cancer Extensive StageSmall Cell Lung Cancer Limited Stage
Shanghai Chest Hospital is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC), Stage II-III Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Cancer.
The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Chest Hospital
How many clinical trials has Shanghai Chest Hospital sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Shanghai Chest Hospital, of which 8 are actively recruiting participants. These trials cover conditions including Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC), Stage II-III Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Chest Hospital research focus on?
Shanghai Chest Hospital clinical trials span Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC), Stage II-III Non-small Cell Lung Cancer, Esophageal Squamous Cell Carcinoma, Esophageal Cancer, Metastatic Esophageal Squamous Cell Carcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Chest Hospital clinical trial?
To participate in a Shanghai Chest Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Chest Hospital trials with current recruitment status updated daily.
Clinical Trials by Shanghai Chest Hospital
NCT07058519 Phase 2
Recruiting
A Study of Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC
Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
NCT06437977 Phase 3
Recruiting
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Stage II-III Non-small Cell Lung Cancer
NCT05978193 Phase 2
Recruiting
Radiotherapy Combined With Immunochemotherapy in Metastatic Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
NCT05945745
Recruiting
Molecular Analysis and Treatment Options of SCLC
Small-cell Lung Cancer
NCT06962436
Recruiting
RAB Versus Ultrathin Bronchoscopy With VBN in the Diagnosis of PPNs
Peripheral Pulmonary Nodules
NCT07091305 Phase 2
Recruiting
A Study of QL1706 Combined With Chemotherapy Induction on Sequential Immunotherapy Consolidation in Patients With Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy
Limited-stage Small Cell Lung Cancer (LS-SCLC)
NCT06969014
Recruiting
Transbronchial MWA for Pulmonary Tumors
Lung Cancer
NCT07528066
Recruiting
Downstaging and RATS After Neo-Chemo-IO: Impact on Surgical Outcomes in NSCLC
Neoadjuvant Chemoimmunotherapy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology